First Patient Dosed in CANbridge Pharmaceuticals CAN008 Phase 2 Trial for Treatment of Glioblastoma Multiforme (GBM) in China
BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–CANbridge Pharmaceuticals, Inc., a leading China-based global rare disease-focused biopharmaceutical company…
Londian Wason Signs Cooperation Agreement in Kazakhstan to Jointly Build a High-Performance Electrolytic Copper Foil Production Base with NAIKAN Ltd.
From Robot Companions to Robot Cafe: Star Plus Legend Reimagines Consumer Experiences Through IP+Physical AI
Hong Kong International Wine & Spirits Fair attracts over 8,200 buyers with enthusiastic participation on Public Day
Six dirhams a gate. The real 2026 cost of a Dubai commute and three ways out
Spiking Joins IBM Z Day 2026 Asia Pacific Special Edition Track as a Friend of the IBM Z Community